Ironwood Pharmaceuticals IRWD Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $40.77M— | $0-100% | $40.08M+69.8% | $23.6M+163% | -$37.39M-1,757% | ||
| $443K-3.7% | $460K-3.2% | $475K+1.7% | $467K-2.5% | $479K-1.2% | ||
| $3.65M-4.4% | $3.82M+5.8% | $3.61M-20.2% | $4.52M-14.5% | $5.29M+15.9% | ||
| $5.12M-93.1% | $74.58M+56.7% | $47.58M— | —— | $19.95M+31.2% | ||
| —— | $0-100% | $2K0.0% | $2K-93.5% | $31K— | ||
| —— | $0+100% | -$2K0.0% | -$2K+93.5% | -$31K— | ||
| —— | $122K— | $0-100% | $88K+1,367% | $6K+100% | ||
| $5.02M-93.3% | $75.05M+57.8% | $47.56M— | —— | $19.92M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Ironwood Pharmaceuticals generate?
- Ironwood Pharmaceuticals (IRWD) generated $147.2M in operating cash flow over the trailing twelve months.
- Where does Ironwood Pharmaceuticals's cash flow data come from?
- Every line is extracted from Ironwood Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
